MedPath

Single Portable Pulse-dose-conserving Device vs. Combined Use of Stationary and Portable.

Phase 3
Completed
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
Device: Inogen
Device: Combination system of a portable and a stationary device.
Registration Number
NCT02079753
Lead Sponsor
Hospital Son Espases
Brief Summary

Introduction: Portable oxygen devices simplify and facilitate patient therapy. This study was designed to compare oxygen saturation and patient satisfaction with a portable oxygen concentrator or with a combined system consisting of a fixed device with continuous flow oxygen dispensation and a portable device with pulse dispensation for ambulation.

Methods: This cross-over trial assessed 25 patients with COPD (92% men; mean age 72.2 ± 7.4 years; mean FEV 34.14 ± 12.51%) at four hospitals in Madrid. All patients had previously used the combined system, consisting of a fixed oxygenation system and a portable system for ambulation, with 16 (64%) using stationary and portable concentrators and 9 (36%) using a stationary reservoir and portable liquid oxygen bag. Oxygenation settings at rest and while walking were determined at baseline. Patients were maintained on the previous combined system for one week and then switched to the portable oxygen concentrator for one week. Mean SpO2 over 24 hours was calculated by the software in the oximeter, and compliance was monitored

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
38
Inclusion Criteria
  • aged 40-80 years
  • had been diagnosed with COPD following the GOLD criteria
  • were receiving oxygen therapy using a fixed oxygenation system and a portable system for ambulation
  • without exacerbation during the previous month
  • agreed to participate
Exclusion Criteria
  • terminally ill
  • unable to understand Spanish
  • had high oxygen flow at rest (> 3 lpm)
  • high respiratory frequency at rest (> 32 rpm)
  • were not achieving adequate O2 saturation levels during titration with the portable oxygen source
  • had previously been diagnosed with obstructive sleep apnea hypopnea syndrome (SAHS)
  • were receiving mechanical ventilation.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
single systemInogenInogen One G2 portable concentrator (Inogen)
combined systemCombination system of a portable and a stationary device.During the first visit, the technician installed a reservoir of liquid oxygen (Liberator 30, Caire) and a liquid Stroller oxygen pack (Caire) for patients using liquid oxygen, or a VisionAire5 (Airsep) stationary concentrator and an Inogen One G2 portable (Inogen) concentrator for patients using concentrators.
Primary Outcome Measures
NameTimeMethod
Percentage of time desaturated below 90% using single oxygenation systemday 14

Oxygenation of patient during use of a portable oxygen pulse dose concentrator.

Percentage of time desaturated below 90% when using a combined oxygenation systemat day 7

oxygenation of patient during use of a combined system consisting of a fixed device with continuous flow oxygen dispensation and a portable device with pulse dispensation for ambulation.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Servicio de Neumología. Hospital Clínico de San Carlos. Facultad de medicina. Universidad complutense de Madrid

🇪🇸

Madrid, Spain

© Copyright 2025. All Rights Reserved by MedPath